1985
DOI: 10.1159/000156983
|View full text |Cite
|
Sign up to set email alerts
|

Protective Mechanisms of Experimental Vaccine-Induced Immunity to <i>Pseudomonas aeruginos</i><i>a</i>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1987
1987
1987
1987

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…used as potential P. aeruginosa vaccines. These include LPS [4], endotoxin protein [5], exotoxin [6] 'slime' polysaccharides [7] 'slime' glycolipoprotein [8], cell wall extracts [9], membrane proteins [10], proteoids (protease-elastase) [11], flagella [12], pill [13] and ribosomal [3] as well as other preparations [1][2][3]. Most of these preparations were found to significantly reduce the incidence of animal mortality due to Pseudomonas infection, some of them without and others with visible deleterious side-effects [1][2][3] as well as varying degrees of success in coping with the variability of the serotypes involved in the Pseudomonas infections [1-31.…”
Section: Various Antigenic Preparations Have Beenmentioning
confidence: 99%
See 1 more Smart Citation
“…used as potential P. aeruginosa vaccines. These include LPS [4], endotoxin protein [5], exotoxin [6] 'slime' polysaccharides [7] 'slime' glycolipoprotein [8], cell wall extracts [9], membrane proteins [10], proteoids (protease-elastase) [11], flagella [12], pill [13] and ribosomal [3] as well as other preparations [1][2][3]. Most of these preparations were found to significantly reduce the incidence of animal mortality due to Pseudomonas infection, some of them without and others with visible deleterious side-effects [1][2][3] as well as varying degrees of success in coping with the variability of the serotypes involved in the Pseudomonas infections [1-31.…”
Section: Various Antigenic Preparations Have Beenmentioning
confidence: 99%
“…Despite the availability of potent antibiotics, the mortality from Pseudomonas aeruginosa infections remains a major medical problem due to the multiple drug resistance of this bacterium [1]. Since certain individuals have an essentially high risk for infection with Pseudomonas, there is a growing interest in the development of a vaccine against it [1][2][3].…”
Section: Introductionmentioning
confidence: 99%